262 related articles for article (PubMed ID: 38213795)
1. Proteome-Wide Fragment-Based Ligand and Target Discovery.
Forrest I; Parker CG
Isr J Chem; 2023 Mar; 63(3-4):. PubMed ID: 38213795
[TBL] [Abstract][Full Text] [Related]
2. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
3. Ligand and Target Discovery by Fragment-Based Screening in Human Cells.
Parker CG; Galmozzi A; Wang Y; Correia BE; Sasaki K; Joslyn CM; Kim AS; Cavallaro CL; Lawrence RM; Johnson SR; Narvaiza I; Saez E; Cravatt BF
Cell; 2017 Jan; 168(3):527-541.e29. PubMed ID: 28111073
[TBL] [Abstract][Full Text] [Related]
4. NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.
Ward CC; Kleinman JI; Nomura DK
ACS Chem Biol; 2017 Jun; 12(6):1478-1483. PubMed ID: 28445029
[TBL] [Abstract][Full Text] [Related]
5. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs.
Wang Y; Dix MM; Bianco G; Remsberg JR; Lee HY; Kalocsay M; Gygi SP; Forli S; Vite G; Lawrence RM; Parker CG; Cravatt BF
Nat Chem; 2019 Dec; 11(12):1113-1123. PubMed ID: 31659311
[TBL] [Abstract][Full Text] [Related]
6. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes.
Chen Y; Craven GB; Kamber RA; Cuesta A; Zhersh S; Moroz YS; Bassik MC; Taunton J
Nat Chem; 2023 Nov; 15(11):1616-1625. PubMed ID: 37460812
[TBL] [Abstract][Full Text] [Related]
7. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
Li J; Wang G; Ye M; Qin H
Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
[TBL] [Abstract][Full Text] [Related]
8. Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes.
Huang T; Hosseinibarkooie S; Borne AL; Granade ME; Brulet JW; Harris TE; Ferris HA; Hsu KL
Chem Sci; 2021 Jan; 12(9):3295-3307. PubMed ID: 34164099
[TBL] [Abstract][Full Text] [Related]
9. Chemoproteomic-enabled phenotypic screening.
Conway LP; Li W; Parker CG
Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
[TBL] [Abstract][Full Text] [Related]
10. Proteome-wide covalent ligand discovery in native biological systems.
Backus KM; Correia BE; Lum KM; Forli S; Horning BD; González-Páez GE; Chatterjee S; Lanning BR; Teijaro JR; Olson AJ; Wolan DW; Cravatt BF
Nature; 2016 Jun; 534(7608):570-4. PubMed ID: 27309814
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based covalent ligand discovery.
Lu W; Kostic M; Zhang T; Che J; Patricelli MP; Jones LH; Chouchani ET; Gray NS
RSC Chem Biol; 2021 Apr; 2(2):354-367. PubMed ID: 34458789
[TBL] [Abstract][Full Text] [Related]
12. Lysine-Targeted Inhibitors and Chemoproteomic Probes.
Cuesta A; Taunton J
Annu Rev Biochem; 2019 Jun; 88():365-381. PubMed ID: 30633551
[TBL] [Abstract][Full Text] [Related]
13. Mapping the Evolution of Activity-Based Protein Profiling: A Bibliometric Review.
Porta EOJ
Adv Pharm Bull; 2023 Nov; 13(4):639-645. PubMed ID: 38022804
[TBL] [Abstract][Full Text] [Related]
14. Chemoproteomic Approaches to Studying RNA Modification-Associated Proteins.
Dai W; Yu NJ; Kleiner RE
Acc Chem Res; 2023 Oct; 56(19):2726-2739. PubMed ID: 37733063
[TBL] [Abstract][Full Text] [Related]
15. Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles.
Gupta V; Yang J; Liebler DC; Carroll KS
J Am Chem Soc; 2017 Apr; 139(15):5588-5595. PubMed ID: 28355876
[TBL] [Abstract][Full Text] [Related]
16. Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery.
Berger AB; Vitorino PM; Bogyo M
Am J Pharmacogenomics; 2004; 4(6):371-81. PubMed ID: 15651898
[TBL] [Abstract][Full Text] [Related]
17. Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots.
Roberts AM; Ward CC; Nomura DK
Curr Opin Biotechnol; 2017 Feb; 43():25-33. PubMed ID: 27568596
[TBL] [Abstract][Full Text] [Related]
18. Chemoproteomics and Chemical Probes for Target Discovery.
Drewes G; Knapp S
Trends Biotechnol; 2018 Dec; 36(12):1275-1286. PubMed ID: 30017093
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed proteomic profiling of cysteine reactivity and ligandability in human T cells.
Vinogradova EV; Cravatt BF
STAR Protoc; 2021 Jun; 2(2):100458. PubMed ID: 33899026
[TBL] [Abstract][Full Text] [Related]
20. Applications of Reactive Cysteine Profiling.
Backus KM
Curr Top Microbiol Immunol; 2019; 420():375-417. PubMed ID: 30105421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
